See more : Cookpad Inc. (CKPDY) Income Statement Analysis – Financial Results
Complete financial analysis of Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beijing Science Sun Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Centrepoint Alliance Limited (CAF.AX) Income Statement Analysis – Financial Results
- SFSB, Inc. (SFBI) Income Statement Analysis – Financial Results
- FullNet Communications, Inc. (FULO) Income Statement Analysis – Financial Results
- Premium Brands Holdings Corporation (PRBZF) Income Statement Analysis – Financial Results
- Lingyuan Iron & Steel Co., Ltd. (600231.SS) Income Statement Analysis – Financial Results
Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ssyy.com.cn
About Beijing Science Sun Pharmaceutical Co., Ltd.
Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulatory, nervous systems, and other areas. The company was founded in 1999 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 476.57M | 734.55M | 1.05B | 1.09B | 1.19B | 1.43B | 749.99M | 616.24M | 607.14M | 589.85M | 480.21M | 396.01M | 245.02M |
| Cost of Revenue | 140.94M | 171.61M | 182.12M | 177.34M | 176.79M | 195.96M | 175.97M | 203.29M | 238.27M | 225.03M | 189.52M | 147.76M | 124.53M |
| Gross Profit | 335.63M | 562.94M | 868.68M | 916.88M | 1.01B | 1.23B | 574.02M | 412.95M | 368.86M | 364.82M | 290.70M | 248.25M | 120.50M |
| Gross Profit Ratio | 70.43% | 76.64% | 82.67% | 83.79% | 85.15% | 86.28% | 76.54% | 67.01% | 60.75% | 61.85% | 60.53% | 62.69% | 49.18% |
| Research & Development | 77.73M | 100.63M | 103.84M | 71.67M | 50.38M | 31.93M | 16.26M | 27.47M | 29.69M | 32.51M | 16.35M | 14.86M | 0.00 |
| General & Administrative | 21.02M | 16.32M | 52.10M | 18.88M | 10.31M | 14.04M | 10.67M | 12.75M | 11.53M | 5.26M | 5.98M | 8.19M | 18.20M |
| Selling & Marketing | 230.43M | 368.84M | 555.16M | 626.67M | 763.06M | 828.43M | 221.02M | 88.83M | 78.25M | 76.75M | 63.15M | 57.18M | 7.49M |
| SG&A | 251.45M | 385.16M | 607.26M | 645.55M | 773.37M | 842.47M | 231.69M | 101.58M | 89.79M | 82.01M | 69.13M | 65.37M | 25.70M |
| Other Expenses | -115.29M | 133.20M | 149.82M | 13.40M | 1.01M | -148.03K | -1.00M | 1.34M | 698.36K | -14.03M | -2.71M | 6.89M | 5.76M |
| Operating Expenses | 213.89M | 527.78M | 767.05M | 782.64M | 884.98M | 936.65M | 286.41M | 167.12M | 154.45M | 147.02M | 114.56M | 103.32M | 27.76M |
| Cost & Expenses | 354.83M | 699.38M | 949.17M | 959.98M | 1.06B | 1.13B | 462.38M | 370.42M | 392.72M | 372.05M | 304.07M | 251.08M | 152.29M |
| Interest Income | 1.10M | 485.66K | 11.56M | 13.60M | 14.78M | 1.25M | 1.15M | 1.31M | 4.91M | 16.23M | 7.93M | 2.34M | 0.00 |
| Interest Expense | 55.26K | 34.00K | 255.19K | 177.42K | 140.63K | 1.14M | 1.11M | 1.28M | 4.87M | 16.21M | 47.40K | 99.24K | 0.00 |
| Depreciation & Amortization | 48.74M | 47.60M | 55.68M | 36.96M | 25.85M | 22.75M | 18.24M | 18.62M | 17.83M | 16.92M | 13.28M | 9.50M | -290.04K |
| EBITDA | 8.60M | 71.64M | 451.23M | 160.54M | 158.36M | 326.82M | 305.95M | 264.44M | 232.24M | 234.72M | 189.42M | 154.43M | 92.74M |
| EBITDA Ratio | 1.80% | 11.39% | 42.94% | 20.50% | 12.63% | 22.89% | 41.24% | 42.92% | 38.33% | 39.81% | 39.95% | 38.93% | 37.89% |
| Operating Income | 121.74M | 254.64M | 439.00M | 179.92M | 177.17M | 330.77M | 332.39M | 298.96M | 242.54M | 233.91M | 183.87M | 147.48M | 93.12M |
| Operating Income Ratio | 25.54% | 34.67% | 41.78% | 16.44% | 14.88% | 23.17% | 44.32% | 48.51% | 39.95% | 39.66% | 38.29% | 37.24% | 38.00% |
| Total Other Income/Expenses | 426.85K | -20.48K | 25.03K | -626.27K | -4.43M | -148.03K | -1.11M | 909.14K | 698.36K | 2.17M | 2.95M | 6.89M | 5.76M |
| Income Before Tax | 122.16M | 254.62M | 439.02M | 179.29M | 172.74M | 330.62M | 331.39M | 300.19M | 243.24M | 236.08M | 186.82M | 154.37M | 98.88M |
| Income Before Tax Ratio | 25.63% | 34.66% | 41.78% | 16.39% | 14.50% | 23.16% | 44.19% | 48.71% | 40.06% | 40.02% | 38.90% | 38.98% | 40.36% |
| Income Tax Expense | 25.76M | 51.97M | 43.89M | 28.01M | 25.18M | 47.46M | 49.86M | 41.85M | 34.01M | 33.65M | 26.07M | 21.79M | 14.18M |
| Net Income | 102.92M | 204.73M | 402.27M | 154.90M | 148.64M | 283.11M | 281.60M | 258.41M | 209.27M | 202.57M | 160.79M | 132.57M | 84.66M |
| Net Income Ratio | 21.60% | 27.87% | 38.28% | 14.16% | 12.48% | 19.83% | 37.55% | 41.93% | 34.47% | 34.34% | 33.48% | 33.48% | 34.55% |
| EPS | 0.21 | 0.43 | 0.84 | 0.32 | 0.31 | 0.59 | 0.59 | 0.54 | 0.50 | 0.56 | 0.45 | 0.37 | 0.26 |
| EPS Diluted | 0.21 | 0.43 | 0.84 | 0.32 | 0.31 | 0.59 | 0.59 | 0.54 | 0.50 | 0.56 | 0.45 | 0.37 | 0.26 |
| Weighted Avg Shares Out | 490.08M | 481.67M | 481.67M | 481.67M | 481.67M | 479.84M | 477.30M | 478.53M | 420.65M | 360.13M | 359.30M | 360.73M | 332.00M |
| Weighted Avg Shares Out (Dil) | 490.08M | 481.67M | 481.67M | 481.67M | 481.67M | 479.84M | 477.30M | 478.53M | 420.65M | 360.13M | 359.30M | 360.73M | 332.00M |
Source: https://incomestatements.info
Category: Stock Reports